Risk-Benefit Trade-Offs for Whole Genome Sequencing
The objective of this award is to evaluate the benefit-risk trade-offs of genomic sequencing technologies from an individual perspective -how patients make decisions about sequencing and from a societal perspective - how sequencing may impact the health care system.
Funding: NHGRI (R01 HG007063)
Timeframe: 02/15/2013 – 01/31/2017
Reimbursement for Whole Exome Sequencing: UCSF as Case Study
The objective of this award is to examine the adoption and reimbursement of Whole Exome Sequencing for pediatric and adult conditions and the implications for clinical care and health policy.
Funding: UCSF Institute for Human Genomics
Timeframe: 01/01/2017 – 12/31/2017
Developing Evidence on Reimbursement for the UCSF500 Tumor Profiling Panel Test
Our objective is to collect evidence on reimbursement challenges for Cancer Tumor Profiling (UCSF500) tests and explore how those challenges could be addressed. The goal is to obtain preliminary data and develop a multi-disciplinary team of collaborators that can compete for larger grant funding.
Funding: NUCSF Research Administration Program
Genomic sequencing to aid diagnosis in pediatric and prenatal practice
The center grant will focus on generating and analyzing evidence regarding the clinical utility of genome sequencing from the perinatal period into early childhood through examining clinical utility, ethical implications, payer coverage, and data integration in a diverse population.
Funding: NIH/NHGRI (U01HG009599)
Timeframe: 08/01/2017 – 05/31/2021